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Asthma is a complex syndrome with signiﬁcant consequences for those affected. The number of in-
dividuals affected is growing, although the reasons for the increase are uncertain. Ensuring the effective
management of potential exposures follows from substantial evidence that exposure to some chemicals
can increase the likelihood of asthma responses. We have developed a safety assessment approach
tailored to the screening of asthma risks from residential consumer product ingredients as a proactive
risk management tool. Several key features of the proposed approach advance the assessment resources
often used for asthma issues. First, a quantitative health benchmark for asthma or related endpoints
(irritation and sensitization) is provided that extends qualitative hazard classiﬁcation methods. Second, a
parallel structure is employed to include dose-response methods for asthma endpoints and methods for
scenario speciﬁc exposure estimation. The two parallel tracks are integrated in a risk characterization
step. Third, a tiered assessment structure is provided to accommodate different amounts of data for both
the dose-response assessment (i.e., use of existing benchmarks, hazard banding, or the threshold of
toxicological concern) and exposure estimation (i.e., use of empirical data, model estimates, or exposure
categories). Tools building from traditional methods and resources have been adapted to address speciﬁc
issues pertinent to asthma toxicology (e.g., mode-of-action and dose-response features) and the nature
of residential consumer product use scenarios (e.g., product use patterns and exposure durations). A case
study for acetic acid as used in various sentinel products and residential cleaning scenarios was devel-
oped to test the safety assessment methodology. In particular, the results were used to reﬁne and verify
relationships among tiered approaches such that each lower data tier in the approach provides a similar
or greater margin of safety for a given scenario.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The increasing prevalence of asthma in the United States, and
worldwide, is a growing burden on health care costs and quality of
life (Centers for Disease Control and Prevention (CDC), 2015a).
Asthma is a chronic inﬂammatory disease of the lung characterized
by a narrowing of the airways that commonly presents with
symptoms of cough, wheeze, dyspnea, and chest tightness (Beckett,
2008). Numerous epidemiological studies have linked the use of
cleaning products in residential and commercial settings to anlege of Medicine, 160 Panzeca
).
Inc. This is an open access article uincrease in physician-diagnosed asthma (Zock et al., 2007), how-
ever the current evidence is not sufﬁcient to determine a clear
dose-response relationship between speciﬁc cleaning product ex-
posures and the development of asthma. Most cases of asthma are
caused or triggered by speciﬁc or non-speciﬁc inﬂammation. Spe-
ciﬁc inﬂammation is often the result of an immunoglobin E (IgE)
mediated response, but some low-molecular-weight (LMW)
chemicals (e.g., toluene diisocyanate), in some cases, may cause IgE
independent inﬂammation (Mapp et al., 1994; Walker et al., 1992).
Single exposures to high concentrations of chemical irritants (e.g.,
hydrogen chloride) can also cause an asthma-like condition called
reactive airways dysfunction syndrome (RADS) (Bernstein, 1993).
Since the pathological mechanisms of asthma are not fully under-
stood, safety assessments for chemicals and products need to
address uncertainties in estimating the dose-response relationshipnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations
ACGIH American Conference of Governmental Industrial
Hygienists®
ACI American Cleaning Institute
ADI acceptable daily intake
AIHA American Industrial Hygiene Association
AOEC Association of Occupational and Environmental Clinics
CDC Centers for Disease Control and Prevention
EL exposure limit
EGV exposure guide value
DFG German Research Foundation
DNEL derived no-effect level
ECETOC European Center for Ecotoxicology and Toxicology of
Chemicals
ECHA European Chemicals Agency
FSA free surface area
GPMT Guinea Pig Maximization Test
HBGV health-based guidance value
IgE Immunoglobin E
IPCS International Programme on Chemical Safety
LLNA Local Lymph Node Assay
LMW low molecular weight
MAK Maximale arbeitsplatz-konzentration (maximum
workplace concentration)
MCCEM Multi-Chamber Concentration and Exposure Model
MOE margin of exposure
MOS margin of safety
NIOSH National Institute for Occupational Safety and Health
NOAEC no observed adverse effect concentration
NOAEL no observed adverse effect level
OEB occupational exposure band
OEL occupational exposure limit
OSHA Occupational Safety and Health Administration
PHBGV provisional health-based guidance value
POD point of departure
ppm parts per million
RADS Reactive Airways Dysfunction Syndrome
REACH Registration Evaluation Authorization and Restriction
of Chemical Substances
RfC reference concentration
RIVM National Institute for Public Health and the
Environment (Netherlands)
rLLNA Respiratory Local Lymph Node Assay
SAF sensitization assessment factor
SCOEL European Union Scientiﬁc Committee on Occupational
Exposure Limits
SP sentinel product
STEL short-term exposure limit
TDI Toluene-2, 4-Diisocyanate
TLV Threshold Limit Value®
TTC threshold of toxicological concern
TWA time-weighted average
UF uncertainty factor
UNECE United Nations Economic Commission for Europe
U.S. EPA U.S. Environmental Protection Agency
VOC volatile organic compound
WOE weight of evidence
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these effects and asthma responses.
Residential consumer product use represents a complex variety
of exposure scenarios, and cleaning product use is no exception.
Exposures may be single events, a series of repeated events, or a
continuous exposure to: (a) a single chemical from a single product,
(b) a single product containing multiple chemicals, (c) a single
chemical in multiple different products, or (d) multiple chemicals
frommultiple products. Product use and application (e.g., spraying,
wiping, or pouring) also affects the overall emission and, therefore,
exposure levels of the various chemicals within a product (Saito
et al., 2015). For example, chemicals from a cleaning product
applied via a spray applicator will be suspended in the air and
present in the breathing zone longer than chemicals from other
applications (Singer et al., 2006). The air concentration is also
impacted by product parameters such as viscosity and delivery
properties of the nozzle. Additionally, cleaning product users may
inhale product ingredients as vapors, dry product particulates, or
liquid aerosols, which affects lung deposition rates. Some of these
ingredients may induce toxicological endpoints related to asthma
or asthma-like responses, such as respiratory sensitization or irri-
tation, through multiple modes of action (Maier et al., 2014).
Furthermore, some chemicals have the potential to induce sensi-
tization following dermal exposure, and subsequent inhalation
challenges may result in asthma-like responses (Arts et al., 2008;
Maier et al., 2014). For these chemicals, it is important that aggre-
gate exposure from both dermal and inhalation exposures be
conducted in an exposure assessment since, in some cases, both
pathways may contribute to overall risks of asthma responses.
The primary focus of this effort is to create a set of preferredmethods for estimation of systemic and respiratory tract exposure
and dose based on differing levels of sophistication that are tailored
for cleaning product use scenarios relevant for respiratory tract
responses. Thus, this approach can be viewed as a reﬁnement of
current cleaning product exposure guidance that is tailored to the
exposure pathways most relevant to asthma or bronchial irritation
as a health endpoint of interest. We array a suite of methods for
application to scenarios that address the unique character of
asthma etiology and pathophysiology and exposures to cleaning
products. The resulting approach is a tiered assessment framework
that provides a margin of safety estimate for cleaning product use
and asthma responses (Fig. 1). In arraying the available tools for
exposure assessment and doseeresponse assessment, three
possible tiers (or categories) would be identiﬁed broadly as (1)
empirical data, (2) vetted model estimates, and (3) worse-case
estimates from basic physiochemical models. Using a suite of
tools arrayed in a tiered approachmaximizes the interplay between
conﬁdence in the assessment outcome and data availability and
assessment resources. The idea of using a tiered safety assessment
approach is becoming increasingly formalized in risk assessment
protocols (e.g., Meek et al., 2011) and is of particular utility for
endpoint speciﬁc assessments for which data sets of variable
completeness are likely to be encountered.2. Methods
The three-tiered approach, shown in Fig. 2 was developed for
conducting an exposure and hazard characterization assessment
for the different scenarios identiﬁed for cleaning product use. The
tiers start with the gathering of available information, such as direct
Fig. 1. A tiered evaluation approach for safety assessment (ADI e Acceptable Daily Intake; DNELs - Derived No-Effect Level; TTC e Threshold of Toxicological Concern).
Fig. 2. Tiered assessment overview (DNEL e derived No-Effect level; OEL e occupational exposure limit; RfC e Reference concentration; TLV e threshold limit Value®; TTC e
threshold of toxicological concern).
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guidance values, and proceeds to subsequent tiers when available
information is lacking. Although developing guidance values for
endpoints such as sensitization is challenging, methods are gaining
ground for developing inhalation-based exposure guidance for
such endpoints from animal toxicology models (e.g., Arts et al.,
2008; International Program on Chemical Safety (IPCS), 2012;
Pauluhn and Poole, 2011; Pauluhn, 2014). The proposed framework
can accommodate varying levels of data for both doseeresponse
and exposure characterization. Each subsequent tier has less reli-
able available information, and thus relies on increasingly precau-
tionary default estimations.
2.1. General tiered exposure assessment approach
The ﬁrst step of exposure assessment is developing a repre-
sentative exposure scenario. This scenario is designed to focus on
the health risk (speciﬁcally asthma) from any identiﬁed chemical
occurringwithin a cleaning product. As is usually the case in human
health safety assessment, this requires the determination and
integration of the hazard potential of that chemical along with the
estimated level of actual exposure to the chemical. Thus, the critical
ﬁrst step is the identiﬁcation of the speciﬁc cleaning product(s) in
which the chemical is used.
The chemical of interest may occur in many cleaning products
and these products could typically have varying concentrations or
dilutions, many uses, and, subsequently, many potential use sce-
narios. Typically only one or a few sentinel products (SPs) are
needed to account for the majority of the human exposure asso-
ciated with a speciﬁc chemical within that class of products (e.g.,
cleaning products). This simpliﬁes the exposure assessment pro-
cess for an individual chemical because the evaluation of exposure
for that chemical within a subset of products deﬁnes a reasonable
worst case. This phenomenon occurs because only one or a few
products have a combination of factors that essentially maximize
the exposure to that chemical (Jayjock et al., 2009; Supplement 1).
For this assessment tool the SP use scenarios were subjected to a
series of standardized questionswith the best information available
being supplied by the manufacturers (Table 1).
Tier 1 is the derivation of human exposure estimates relevant to
each scenario from empirical exposure data identiﬁed in the liter-
ature. Obtaining good measured exposure data on a product's use
represents the “gold standard” of exposure assessment and is thus
highly desirable. These data are usually quite rare in the open sci-
entiﬁc or trade journal literature.
An important part of any measurement of chemical exposure is
the ability to match or associate the measured exposure with the
conditions that actually caused the exposure. These factors are
commonly associated with the product use. However, the exposure
data do not necessarily have to be for the chemical of interest but
only some identiﬁed chemical during the product use. GivenTable 1
Standardized questions for sentinel products (SPs) use scenarios.
1. What is the amount of total product and/or solution (as applicable) used per typica
2. What is the frequency of use? What is the typical and maximum number of times
3. How is the product delivered and applied? Is it applied by propellant aerosol spray
designed to be released directly into the air (e.g., air sanitizers), on to speciﬁed surfa
skin contact and/or airborne exposures likely?
4. What is the duration of use per scenario typical and maximum duration in minute
5. Are there potentially hazardous chemicals in the product other than the chemical o
6. Is the product's use seasonal; that is, is it predominantly used in an indoor spac
conditioning)?
7. Is it used indoors or outdoors exclusively or predominantly?
8. If used indoors, which rooms or spaces is it typically used (e.g., bathroom, laundryinformation such as the percentage of the compound measured,
matched to the percentage of the chemical of interest, the exposure
potential for the chemical of interest can be scaled. In addition,
some available data, especially physical-chemical properties may
be valuable to application of this approach. For example, the
equilibrium headspace concentration of the chemical within its
product container could be quite valuable for modeling.
In the absence of empirical exposure data, the tier 2 approach is
used. Tier 2 is the development of human inhalation exposure es-
timates using modeled data from the best publicly available con-
sumer product models for aerosols and vapors, for example, U.S.
Environmental Protection Agency (U.S. EPA) Multi-Chamber Con-
centration and Exposure Model (MCCEM) (U.S. EPA, 2001) or the
National Institute of Public Health and the Environment (RIVM)
CONSEXPO-4.1 model (RIVM, 2013). This approach has been
demonstrated for individual ingredients (Fedoruk et al., 2005). In
addition, multiple-ﬁeld models, such as those available in the
American Industrial Hygiene Association's (AIHA) industrial hy-
giene exposure assessment modules (IH MOD), are routinely used
in industrial hygiene applications and are applicable for consumer
products ((AIHA, 2013). Please refer to Supplemental Section 1.2 for
additional information.
For the case study presented in this paper we use IHMOD (AIHA,
2013) and breathing rate (as a function of age and activity level to
demonstrate the Tier 2 approach (U.S. EPA, 2011). This modeling
approach using IH_MOD allows for a completely transparent
analysis of the exposure potential given reasonable amounts and
quality of input data. Another more consolidated series of models is
available in which some of the inputs and exposure assessment
engines are integrated within the model structure; namely, the
Consumer Exposure Model, CONSEXPO-4.1 (RIVM, 2013). Where
appropriate and deemed useful, the scenarios were also modeled
using CONSEXPO-4.1 and the results presented together for the
case study. In future applications the user can select the model that
is most appropriate for the consumer use scenario being assessed
as part of the Tier 2 process.
It is anticipated that information for Tier 2 analysis will usually
be available. In instances where the information is so lacking that
Tier 2 approaches could not be used, a Tier 3 method would be
used. Tier 3 is the development of generalized human exposure
estimates from basic chemical and physical principles resulting in a
screening or worst-case scenario exposure estimate. Given an
exposure limit (EL), a categorical exposure banding scheme based
on exposure limit fractions (Table 2) or potency (Table 3) becomes a
straightforward proposition (Supplemental 1.3). This scheme can
be extended to No Observed Adverse Effect Levels (NOAELs) given
some assumptions. Banding exposure potential without explicit
consideration or an absolute tie to toxicology is possible, but
considerably more uncertain. As such, only three bands are desig-
nated for the potency-based banding scheme for this assessment
method: Low, Medium, or High.l use?
per day, week, month, and/or year the product might be used?
, trigger spray, or pour-to-dilute then pour and wipe or just pour and wipe? Is it
ces or into a vessel (e.g., washing machine)? Based on how the product is used, are
s/day?
f interest such that they drive the risk of overexposure?
e with open windows or closed windows (typically winter or summer with air
room, closet)?
Table 2
Categorical exposure banding scheme based on exposure limit fraction.
Exposure Category Estimated exposure potential
Fraction of the toxicological benchmarka
Very Low <0.1
Low 0.1 to 0.5
Med 0.5 to 1.0
High >1.0
a Identiﬁed health-based guidance values from Tier1 or Provisional Safe Doses
from Tier 2 or Threshold of Toxic Concern developed in Tier 3 of the tiered hazard
assessment approach.
Table 3
Categorical exposure banding scheme based on potency.
Exposure Category Estimated exposure potential (mg/day)a
Low (1) <0.1
Medium (2) 0.1 to 0.3
High (3) >0.3
a Note: This banding is speciﬁcally based on exposure in the context of potential
Asthma risk with category indexed to the Asthma Threshold of Toxicological
Concern (TTC) approach as described for Tier 3 hazard assessment.
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Tier 1 identiﬁes inhalation health-based guidance values
derived by international organizations for asthmagenic materials.
Developing guidance values for endpoints such as sensitization is
challenging and typically relies on well-constructed epidemiology
and controlled exposure studies. A fully validated animal-based
toxicology study design has yet to be routinely used, although
methods are gaining ground for developing inhalation-based
exposure guidance for such endpoints from animal toxicology
models (e.g., Arts et al., 2008; Dotson et al., 2015; IPCS, 2012;
Pauluhn and Poole, 2011; Pauluhn, 2014; Sarlo and Clark, 1992).
Examples of existing health-based guidance values are occupa-
tional exposure limits (OELs) based on respiratory sensitization
responses (American Conference of Governmental Industrial Hy-
gienists (ACGIH), 2011). When multiple guide values exist, decision
tools can be applied to select the most appropriate “best” exposure
limit based on criteria of relevance, reliability, and conﬁdence levels
(Deveau et al., 2015).
Evaluation of an exposure limit that is relevant and reliable
takes into consideration the intended use of the existing value and
the application for safety assessment for potential asthma effects
from residential consumer product exposures. For this framework
relevant exposure limits would be limited to those based on asthma
or health effects that have been shown to be related to asthma (e.g.
irritation and sensitization). Modiﬁcation of existing exposure
guides to consider the temporal patterns of residential consumer
product exposures as well as potential differences in response
among exposed populations may be appropriate. An approach for
conversion of occupationally-based exposure guide values to tem-
poral patterns relevant for residential consumer product exposure
is shown in Fig. 3.
In the absence of a relevant and reliable Exposure Guide Value
(EGV), a Tier 2 approach is conducted. A Tier 2 process involves (1)
identiﬁcation or development of a provisional health-based guid-
ance value (PHBGV) for worker and consumer inhalation scenarios
using an approach similar to the current Registration Evaluation
Authorization and Restriction of Chemical Substances (REACH)
derived no-effect level (DNEL) approach for dermal sensitization
and (2) a Hazard Banding approach. An occupational exposure band
(OEB or Hazard Band) approach (United Nations Economic Com-
mission for Europe (UNECE), 2011) that is modiﬁed to betteraddress irritation and sensitization has been developed (Table 4;
see supplemental section 2.1 and Table S2.1 for EGV ranges and
detailed criteria from standardized tests). Brieﬂy, substances are
grouped into four hazard bands based on severity of sensitization
and irritation of the respiratory tract and skin. Each hazard band is
assigned a target maximum concentration (or a range of exposure
limits) that should not be exceeded for each band. Judgments about
the relationship between a speciﬁc effect and the potential for
developing an asthma response can be considered and effects or
assay results can be grouped into relative potency bands.
Once the appropriate hazard band has been established, the
exposure limit ranges applicable to the band are considered as
provisional safe dose/concentrations used to support developing
exposure control requirements.
Absent available data to determine a provisional safe dose, a Tier
3 approach is used. Tier 3 characterizes asthma hazard using a
Threshold of Toxicological Concern (TTC) (Barlow, 2005) approach.
Although this approach is widely accepted for assessing food safety,
there is no current validated approach for assessing respiratory
toxicity or, more speciﬁcally, asthma or sensitization of the respi-
ratory tract. However, proposed extensions of the TTC method
adapted for sensitization outcomes (Safford, 2008) as well as
inhalation exposures (e.g.,Carthew et al. (2009); Dolan et al. (2005))
have been developed. For this assessment a TTC of 0.01 mg/m3 was
derived based on the distribution of EGVs for chemicals associated
with asthma responses (see supplemental 2.2 for more information
on the derivation of this estimate).
2.3. Risk characterization approach
The human exposure estimates and dose-response information
were evaluated by deriving a margin of safety (MOS) that compares
the inhalation guidance value, provisional safe dose, or TTC value to
the human exposure estimates based on measured data, modeled
data, or screening level assessment. The MOS is proposed here
instead of a margin of exposure (MOE) since the optimum health
benchmarks are presented as full safe exposure concentration
equivalents, such as an EPA Reference Concentration (RfC). A MOE
that compares the most relevant and representative reported No
Observed Adverse Effect Concentration (NOAEC) with the human
exposure estimate could also be calculated.
3. Case study: acetic acid
Acetic acid was chosen for use in this case study because it 1) is
an irritant, 2) is widely used in both homemade and commercially
produced cleaning products, and 3) has a large database of infor-
mation on both exposure and health effects. Acetic acid has the
potential to induce asthma or trigger asthma symptoms via irrita-
tion, one of the etiological factors for asthma induction (Dotson
et al., 2015), and has been labeled an “asthmagen” by the Associ-
ation of Occupational and Environmental Clinics (AOEC, 2012).
3.1. Exposure assessment
Acetic acid occurs at varying concentrations in many cleaning
products with multiple uses (Air Products & Chemicals, Inc., 2012;
Ecolab Inc, 2012; Ewer, 2013; Soukup, 2013; U.S. EPA, 2003;
Women's Voices for the Earth, 2010). Typically only one or a few
types of products account for the majority of human exposure to
the ingredient of interest (in this case, acetic acid), thus a repre-
sentative sentinel product is selected for the exposure assessment
(Jayjock et al., 2009). In the case of acetic acid, our search and
consultationwithmanufacturers of cleaning products yielded three
SPs (Table 5) with acetic acid concentrations for further evaluation.
Fig. 3. Conversion of exposure guide values (EGVs) to consumer-speciﬁc scenarios and exposure patterns (STEL e short-term exposure limit; TWA e time weighted average).
Table 4
Qualitative effect severity categories for allocation of EGVs based on sensitization and irritation of the respiratory tract and skin.
Band A B C D
EGV Range >30 ppm 3e30 ppm 0.3e3 ppm <0.3 ppm
Irritation
Dermal Mild/Moderate Moderate/Severe Severe/Corrosive e
Ocular Mild/Moderate Moderate/Severe Severe/Corrosive e
Respiratory No Evidence Mild/Moderate Moderate/Severe Severe/Corrosive
Sensitization
Dermal No Evidence Weak Evidence Clear Evidence e
Respiratory No Evidence No Evidence Weak Evidence Clear Evidence
Table 5
Sentinel product (SP) Acetic acid concentrations.
Acetic acid SP Residential consumer product
Max conc (wt%)
Residential homemade product
Max conca (wt%)
Reference for residential consumer product
Window Cleaner 0.3 5 Air Products (2012); Soukup (2013)
Floor Cleaner 8 5 US EPA (2003);
Women Voices (2010)
Flat Surface Cleaner 2 7 Ecolab Inc (2012);
Ewer (2013)
a These percentages come from a general internet search of homemade cleaning products. Many websites list recipes for cleaning with distilled white vinegar, which
typically contains 4e10% acetic acid.
A. Maier et al. / Regulatory Toxicology and Pharmacology 73 (2015) 903e913908Recipes for homemade cleaning products that can be made from
common household items, like vinegar, are available on the
Internet (e.g., Good Housekeeping (2015)). Since acetic acid is a
main component of vinegar (by volume), we included acetic acid
concentration estimates for both commercial and homemade
products to test multiple real-world scenarios.
A search of the literature did not reveal empirical exposure data
that could be used to develop a Tier 1 human exposure estimates
for acetic acid for cleaning product use scenarios. The assessmentwasmoved toTier 2; exposuremodeling. This exposuremodeling is
presented as a reasonable worst-case scenario for each SP using the
single value inputs that will provide the highest deterministic level
of concentration and exposure within each scenario. The model
predicted exposure from window and ﬂoor cleaners was higher
than the surface cleaning product, thus the surface cleaner results
are not shown. The SP for window and ﬂoor cleaning products, both
commercial and homemade, were modeled using IH MOD (AIHA,
2013) and CONSEXPO-4.1 (RIVM, 2013) exposure models. The 2-
Table 7
ConsExpo 4.1 inhalation inputs for the window cleaning scenario.
Parameter Value
Exposure duration 50 min
Product amount 500 g
Weight fraction compound 0.3% or 5%
Room volume 30 m3
Ventilation rate (ACH) 0.4/hr
Mode of release Evaporation
Release area (constant) 46.5 m2
Application duration 50 min
Temperature 25 C
Molecular weight 60 g/mol
Vapor pressure 15.6 mmHga
Mass transfer rate 4860 m/min
Molecular weight matrix 18 g/mol
Uptake fraction 1 fraction
Inhalation rate 32.9 m3/day
ACH emixing air changes per hour -/hr; g e gram; % e product percent;
C e Celsius; m e meter; min(s) e minute(s); mmHg e millimeters of
mercury; mol e molecule; hr e hour.
a U.S. National Library of Medicine (2014).
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the selected model within IH MOD. See Tables 6e9 for speciﬁc
customized model inputs.
IH MOD Spreadsheets and CONSEXPO-4.1 ﬁles documenting all
of the input and output values for the modeling are available as
supplemental material (section 1.7 and 1.8). The exposure calcula-
tion for IH MOD results assumes the person leaves the near ﬁeld
and the room after they are done cleaning. Therefore, the model
estimate ends when the event duration ends. The predicted event
time-weighted average (TWA) breathing zone concentration is
multiplied by the hourly breathing rate (1.73 m3/day) and the
exposure duration ratio is then divided by female body weight to
calculate the event exposure dose (e.g., 25 mg/m3 * 1.37 m3/hr * 50/
60 h ÷ 60 kg ¼ 0.5 mg/kg). The 24-hr calculation assumes the
person is not in the near ﬁeld or the room after the cleaning is
completed and that exposure essentially ceases that day. This
exposure is calculated by multiplying the event TWA concentration
by the exposure duration ratio (e.g., 25 mg/m3 * 50 min/
1400 min ¼ 0.9 mg/m3). The predicted 24-hr TWA is used to
calculate the 24-hr exposure dose by multiplying by the daily
breathing rate (20 m3/day) then dividing by female body weight
(e.g., 0.9 mg/m3 * 20 m3/day ÷ 60 kg ¼ 0.3 mg/kg). The predicted
exposures are presented in Tables 10 and 11.
The tiered approach is a top-down method, meaning tier 2 will
have less information than tier 1 and tier 3 will have less than tier 2.
For acetic acid, a tier 3 assessment is not needed for window or
ﬂoor SPs because sufﬁcient information was available for the tier 2
assessment.3.2. Hazard assessment
For acetic acid the relevant exposure guide values were drawn
from the pool of candidate occupational exposure limits from
authoritative organizations (i.e., American Conference of Govern-
mental Industrial Hygienists (ACGIH), National Institute for Occu-
pational Safety and Health (NIOSH), Occupational Safety and Health
Administration (OSHA), Scientiﬁc Committee on Occupational
Exposure Limit Values (SCOEL), German Research Foundation
(DFG)), each based on upper respiratory system irritation and the
potential for chronic respiratory system symptoms, including
decreased pulmonary function. The lowest reliable Occupational
Exposure Value (e.g., OEL) value is 10 ppm (25 mg/m3) as an 8-
h TWA and 15 ppm (37 mg/m3) as a short-term exposure limit
(STEL) (ACGIH, 2013). Table 12 lists values were used to derive the
following consumer safety assessment EGVs (based on the con-
version methodology shown in Fig. 3).
No exposure limits for acetic acid are available based on sensi-
tization of the respiratory tract, respiratory local lymph node assay
(rLLNA), or dermal sensitization/irritation. However, several
agencies have derived a TWAOEL of 25 mg/m3 for acetic acid basedTable 6
IH MOD (2-Zone Model: Near Field Far Field Constant Mass Emission) inhalation inputs
Parameter Value
Room Volume 30 m3
Volume near ﬁeld (hemi-sphere) 0.262 m3
Constant mass emission rate (0.3%) 30 mg/min
Constant mass emission rate (5%) 0.5 g/min
Hemi-sphere surface area 1.571 m2
Beta: air ﬂow between near and far ﬁeld; FSA: free surface area
of the near ﬁeld volume; S: average air ﬂow rate
4.713 m3/min
Room supply/exhaust rate (vol/min) 0.2 m3/min
m emeter; l e length; w e width; h e height; pi e 3.142; r e radius; g e gram; % e pro
average air ﬂow rate; s e seconds; vol e volume; hr e hour.on “the risk of irritation to the eyes, nose, and respiratory tract
associated with exposure to acetic acid” (CDC, 2015b). The Euro-
pean Chemicals Agency (ECHA, 2015) has also derived an inhalation
DNEL of 25 mg/m3 based on local effects for both workers and the
general population. This assessment considers the limit of 25 mg/
m3 for the general population as appropriate for use for Tier II
hazard characterizations for acetic acid. There is, therefore, no need
to derive a separate health-based guidance value (HBGV) based on
an identiﬁed point of departure (POD) and application of assess-
ment factors using the Tier 2 approach for this assessment.
In the absence of a HBGV, a lower-level hazard characterization
for acetic acid involves the use of a hazard-banding approach
(UNECE, 2011) that is modiﬁed from existing protocols to better
address irritation and sensitization endpoints. Table 13 shows the
endpoints for which data identify the appropriate hazard band and
associated consumer EGV range. Note that the assessment is based
on the properties of the pure chemical because the exposure esti-
mates are developed for acetic acid itself. These tables do not
suggest the actual product formulations containing acetic acid
would be severe or corrosive to the skin and eyes. Based on
consideration of the effects of dilution the upper end of the band C
is selected, yielding an EGV of 3 ppm (7.4 mg/m3).
Applying the Tier 3 method, 0.01 mg/m3 is considered the
threshold for EGV estimates based on asthma, barring the avail-
ability of any additional information.
4. Results
An overview of the case study for acetic acid and resulting
assessment determinations are shown in Fig. 4 for the windowfor the window cleaning scenario.
Formula
(L) (W) (H)
2/3 pi (r3) ¼ (0.6666) (3.142) (0.5 m)3
(1 g/ft2) (500 ft2) (0.3/100)/50 min
(1 g/ft2) (500 ft2) (5/100)/50 min
(2pi) (r2) ¼ 2(3.142) (0.5 m)2
½ FSA (S) ¼ (0.5) (3.142 m2)/2(0.1 m/s) (60 s/min)
(Room vol) (Air change rate) ¼ (30 m3) (0.4 Air changes/hr) (1 h/60 min)
duct percent; ft e foot; m emeter; min(s) eminute(s); FSA e free surface area; S e
Table 8
IH MOD (2-Zone Model: Near Field Far Field Constant Mass Emission) inhalation inputs for ﬂoor cleaning scenario.
Parameter Value Formula
Room Volume 30 m3 (L) (W) (H)
Volume near ﬁeld (cylinder) 1.571 m3 (pi) (r2) (h) ¼ (3.142) (0.5 m)2(2 m)
Constant mass emission rate (5%) 3024 mg/min (amt used) (area cleaned) (%) (time) ¼ (5.04 g/ft2) (720 ft2) (5/100)/60 min
Constant mass emission rate (8%) 4838 mg/min (amt used) (area cleaned) (%) (time) ¼ (5.04 g/ft2) (720 ft2) (8/100)/60 min
Cylinder surface area (2pi) (r2) þ (2pi) (r) (h)
Cylinder surface area without the ﬂoor surface area (FSA) 7.069 m2 (pi) (r2) þ (2pi) (r) (h) ¼ (3.142) (0.5 m)2 þ 2(3.142) (0.5 m) (2 m)
Beta: air ﬂow between near and far ﬁeld; FSA: free
surface area of the near ﬁeld volume; S: average air ﬂow rate
21.2 m3/min ½ FSA (S) ¼ (0.5) (7.069 m2) (0.1 m/s) (60 s/min)
Room supply/exhaust rate (vol/min) 0.2 m3/min (Room vol) (Air change rate) ¼ (30 m3) (0.4 air changes/hr) (1 h/60 min)
memeter; le length; wewidth; he height; pie 3.142; re radius; ge gram; %e product percent; fte foot; min(s)eminute(s); FSAe free surface area; Se average air ﬂow
rate; s e seconds; vol e volume; hr e hour.
Table 9
ConsExpo 4.1 inhalation inputs for the ﬂoor cleaning scenario.
Parameter Value
Exposure duration 60 min
Product amount 3600 g
Weight fraction compound 5% or 8%
Room volume 30 m3
Ventilation rate (ACH) 0.4/hr
Mode of release Evaporation
Release area (constant) 46.5 m2
Application duration 60 min
Temperature 25 C
Molecular weight 60 g/mol
Vapor pressure 15.6 mmHga
Mass transfer rate 4860 m/min
Molecular weight matrix 18 g/mol
Uptake fraction 1 fraction
Inhalation rate 32.9 m3/day
ACH emixing air changes per hour -/hr; g e gram; % e product percent;
C e Celsius; m e meter; min(s) e minute(s); mmHg e millimeters of
mercury; mol e molecule; hr e hour.
a NLM (2014).
Table 10
Summary of modeled exposures mg/m3 (mg/kg) for residential consumer products.
Scenarioa Window Floor
Inhalation IH MOD PEAKb 43 7985
Inhalation IH MOD Eventc 29 (0.55) 4470 (102)
Inhalation IH MOD 24 h TWA 1.0 (0.55) 186 (102)
Inhalation CONSEXPO Event 22 (0.41) 1080 (25)
Inhalation CONSEXPO 24 h TWA 0.75 (0.41) 45 (25)
Dermal CONSEXPO Event & 24 h (0.0074) NA
NA ¼ not application e dermal exposure is assumed not to occur in mopping.
a Acetic Acid content: Window Cleaner e 0.3%, Floor Cleaner e 8%.
b Exposure assumed to stop at end of event (i.e., person leaves the area).
c Event breathing rate assumed equal to 1.37 m3/hr (from Consexpo database).
A. Maier et al. / Regulatory Toxicology and Pharmacology 73 (2015) 903e913910cleaning scenario. After assessing all three tiers for hazard assess-
ment, the Tier 1 approach is used for the ﬁnal safety assessment of
acetic acid. A consumer-based EGVwas developed for both task and
24-h daily average exposures. For the exposure assessment the TierTable 11
Summary of modeled exposures mg/m3 (mg/kg) for residential homemade
formulations.
Scenarioa Window Floor
Inhalation IH MOD PEAKb 722 4991
Inhalation IH MOD Eventc 478 (9.1) 2794 (64)
Inhalation IH MOD 24 h TWA 17 (9.1) 116 (64)
Inhalation CONSEXPO Event 370 (7.0) 664 (15)
Inhalation CONSEXPO 24 h TWA 13 (7.0) 28 (15)
Dermal CONSEXPO Event & 24 h (0.12) NA
a Acetic Acid content: Window Cleaner e 5%, Floor Cleaner e 5%.
b Exposure assumed to stop at end of event (i.e., person leaves the area).
c Event breathing rate assumed equal to 1.37 m3/hr (from Consexpo database).2 approach is used for the ﬁnal safety assessment for acetic acid.
Empirical datawere not available for the exposure assessment (Tier
1). The safety assessment method suggests no need for further
action based on the comparison of the 24-h daily exposures to the
relevant consumer duration adjusted EGV since a sufﬁcient margin
of safety suggests low value in additional assessment. In contrast,
the task-based exposure estimates were in excess of the consumer
and duration adjusted EGVs for task scenarios. Although this result
does not necessarily indicate that health effects would occur from
such uses, the result suggests that additional information may be
needed to reﬁne the assessment for task-based exposures. Options
would include, generating Tier 1 exposure assessment data for
task-based exposure assessment, or developing new data to
improve the exposure assessments derived using the Tier 2 expo-
sure assessmentmethods. A similar approachwas used for the ﬂoor
cleaning scenario and resulted in the same conclusions, although
the overall exposure estimates were higher than the window
cleaning scenario.
5. Discussion
In this paper we describe a safety assessment method for eval-
uating residential consumer product ingredients with regard to
their potential for causing asthma responses. The tool was devel-
oped based on cleaning product use scenarios, but could be
extended to address other consumer product categories (e.g., per-
sonal care products, home improvement products, etc.) The pro-
posed method is designed to support assessments for new or
existing product ingredient reviewswith deﬁned use scenarios. The
approach builds on existing risk assessment tools (Maier et al.,
2014) but incorporates features tailored to considerations rele-
vant to asthma and residential consumer product safety assess-
ments. The hazard characterization components favor developing
an exposure guide value based on the most relevant and reliable
data and providing a quantitative potency estimate for assessing
risk. Common screening level risk assessment approaches were
used in the design (e.g., hazard banding (UNECE, 2011)), but
modiﬁed based on analysis of endpoints and hazard data speciﬁc to
asthma, or relevant toxicological endpoints (sensitization or irri-
tation). Although the exposure assessment components are not
unique to asthma endpoints, they have been reﬁned to enhance
applicability to residential consumer product use scenarios.
The method recognizes the need for safety assessments that can
be accomplished with varying degrees of data. Thus, a tiered
assessment methodology was chosen. The use of tiered assess-
ments has been common in chemical risk assessment in programs
for environmental chemical releases and has been incorporated
into new chemical mixtures methods and international frame-
works (Meek et al., 2011). In typical applications, the tiers are
organized such that less data intensive methods using reasonable
Table 12
Consumer safety assessment Exposure Guide Values (EGVs).
EGV Scenario Value
Ceiling limit based
No Ceiling limit available
Tasked-based
Surface Cleaning STEL of 37 mg/m3  15 min STEL/20 min Task Duration/3-fold factor for consumer variability in sensitivity 9.3 mg/m3
Window Cleaning STEL of 37 mg/m3  5 min STEL/50 min Task Duration/3-fold factor for consumer variability in sensitivity 3.7 mg/m3
Floor Cleaning STEL of 37 mg/m3  15 min STEL/60 min Task Duration/3-fold factor for consumer variability in sensitivity 3.1 mg/m3
24-Hour Daily Average
TWA of 25 mg/m3  8 h TWA/24 h Day/3-fold factor for variability in sensitivity 2.8 mg/m3
Table 13
Application of the hazard banding approach for acetic acid.
Band A B C D
EGV Range >30 ppm 3e30 ppm 0.3e3 ppm <0.3 ppm
Irritation
Dermal Mild/Moderate Moderate/Severe Severe/Corrosive e
Ocular Mild/Moderate Moderate/Severe Severe/Corrosive e
Respiratory No Evidence Mild/Moderate Moderate/Severe Severe/Corrosive
Sensitization
Dermal No Evidence Weak Evidence Clear Evidence e
Respiratory No Evidence No Evidence Weak Evidence Clear Evidence
Fig. 4. A summary of the acetic acid case study using the multi-pronged tiered approach for exposure and hazard assessment for a window cleaning scenario (DNEL e Derived No-
Effect Level).
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before more reﬁned methods are applied. This enables screening
many combinations of chemicals and exposure proﬁles for identi-
ﬁcation of those that need a more detailed (and resource intensive)review. Our proposed tieredmethod takes a different approach that
considers both reliability and accessibility of information early in
the process. The initial tier relies on identiﬁcation of high conﬁ-
dence hazard values and empirical exposure data and moves to
A. Maier et al. / Regulatory Toxicology and Pharmacology 73 (2015) 903e913912lower tiers as needed based on limitations in data availability. Since
in most cases the safety assessment tool is used in proposed new
ingredient review situations (rather than to screen hundreds of
existing exposures) the emphasis on high reliability data is favored.
For our case study we found ﬂoor cleaners represent the
dominant SP for inhalation exposure potential, which is inconsis-
tent with the research conducted by Singer et al. (2006); sprays and
wipes are expected to result in higher volatile organic compound
(VOC) and chemical emissions than use of mops. The estimated
exposures are likely much higher than real world exposures; the
estimates predict a signiﬁcant and unacceptable level of predicted
respiratory irritation that is not seen in the real world use of the
product. For example, the ACGIH (2013) OELs derived for acetic
acid, based on ocular and respiratory irritation, are 25 mg/m3 (8-
h TWA) and 37 mg/m3 (STEL); these OELs are much lower than
the model-estimated exposures of >1000 mg/m3 for an “event”, or
short-term exposure, and 45e86 mg/m3 for a 24-h TWA during the
ﬂoor-cleaning scenario (see Tables 10 and 11). If real world expo-
sures were truly as high as those predicted by the models, it would
be expected that the use of acetic acid in ﬂoor cleaning products
would result in signiﬁcant ocular, nasal, and respiratory irritation.
The overestimation is likely the result of an overestimation of the
maximum amount of acetic acid used in any formulation (either 5
or 8 wt%) and a signiﬁcant overestimate of the evaporation rate.
Additional or reﬁned information from manufacturers regarding
the maximum amount of acetic acid in the product would almost
certainly lower this overestimated exposure prediction. The second
source of overestimation, the evaporation rate, could be resolved
using chamber tests. Indeed, this example highlights the imperfect
nature of a screening assessment where analysts are essentially
forced to use default inputs in the absence of more conﬁdent model
inputs born of better monitoring data.
There is a good concordance of estimated exposures between
the predictions of the IH MOD and CONSEXPO-4.1 Model for most
of the comparisons. However, there is a signiﬁcant difference be-
tween the inhalation exposure potential predicted by IH MOD and
the CONSEXPO-4.1Model in the ﬂoor scenario. This is primarily due
to the choice of an assumption for full or complete emission of the
applied acetic acid in the IH MOD modeling versus a generalized
estimated evaporative rate algorithm used in the CONSEXPO-4.1
estimates. The IH MOD assumption is reasonable worst case and
the CONSEXPO-4.1 evaporative rate estimation is most likely closer
to reality, but because it is a generalization it is still uncertain. The
estimates from these two modeling constructs provide a reason-
able portrayal of the uncertainty with a bias toward overestimation
that is typically present in this sort of modeling exercise. However,
users can further evaluate the range of uncertainty in the exposure
estimates based on statistical methods (e.g., using distributions of
empirical exposure data) or model-input driven sensitivity analysis
(by selecting alternative parameter inputs for the exposure models
to estimate ranges).
The case study results support the potential utility of the tiered
approach. The value of the approach would be enhanced by testing
a broader array of chemicals. Such chemicals would ensure the
model is sufﬁciently ﬂexible to address chemicals with a range of
irritant and sensitization potencies as well as diverse physical and
chemical properties. Identifying a likely precautionary stance sug-
gests the need to reﬁne the model estimates or collect empirical
data. In reality for the exposure assessments the use of the Tier 2
modeling approach is likely to be a common starting point for as-
sessments, because Tier 1 empirical monitoring data will often not
be available for speciﬁc scenarios of interest. There are scenarios
where Tier 3 methods may play a larger role for mixed or complex
scenarios that are not well addressed by current modeling tools.
One example is for residential consumer products in the particulatephase or for mixed phase exposures. Our case study was developed
for a volatile product, and additional development of Tier 2
methods for aerosol exposures are likely to be needed. Many or-
ganizations use Tier 3 methods for aerosols based on qualitative
exposure indices based on physical characteristics of solid phase
material (level of dustiness, particle size, etc.) and thus we have
included such an approach where modeling tools are limited.
Although we modeled exposure in terms of dose (mg), and can
estimate dermal exposure and absorption, the interpretation of
such multiple pathway exposures to a total systemic dose is also
uncertain from a toxicological perspective. Although it is recog-
nized that sensitization itself is a systemic effect, the actual dose-
response and route-dependence of exposures for presentation of
asthma responses is a complicating factor (American Cleaning
Institute (ACI), 2012). Thus our Tier 1 hazard approach relies on
inhaled exposures as the key dose-response metric. However,
screening approaches in Tier 2 incorporate indicator effects data
(including skin sensitization and irritation data) as a precaution.
Much validation work is needed to develop understanding of the
quantitative relationships between dermal exposures and asthma
potency. Although the induction of allergy is similar in some re-
spects for skin and respiratory allergic responses (Arts and Kuper,
2007), it is not true for all sensitizers, particularly those that
cannot pass through the skin (Anderson et al., 2011). The hazard
assessment can also be reﬁned as new bioassays targeted for
assessing asthma induction and elicitation potential are developed.
There is signiﬁcant current emphasis in this area (Maier et al.,
2014).
6. Conclusion
Asthma is a serious medical condition and relationships to
chemical exposures from residential consumer products, including
cleaning products, have been described. A comprehensive safety
assessment is an important component of a robust risk mitigation
strategy. The proposed method provides a framework for the sys-
temic development of such safety assessments for consideration of
asthma responses.
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